Teleflex Vascular Intervention

BIOTRONIK Vascular Intervention was a specialized segment of BIOTRONIK SE & Co. KG, a German medical device company established in 1963. The company focused on developing and manufacturing advanced medical devices for cardiovascular care, including products for cardiac rhythm management, electrophysiology, and vascular intervention. With a global presence and multiple research and development centers, BIOTRONIK emphasized innovation in cardiac and vascular therapies. The Vascular Intervention segment offered a comprehensive portfolio of products for treating coronary and peripheral artery diseases. This included drug-coated balloon catheters, covered stents, and self-expanding stents, all designed for minimally invasive procedures to restore blood flow. The segment also featured innovative technologies like the Freesolve Sirolimus-Eluting Resorbable Metallic Scaffold, which combines temporary vessel support with drug delivery. In 2025, Teleflex Incorporated acquired BIOTRONIK’s Vascular Intervention business, aiming to expand clinical trials and market reach for its innovative technologies.

• Employees77
• Founded1943
• Annual Revenue$3041342000